HomeInsightsStock Comparison

Caplin Point Laboratories Ltd vs Natco Pharma Ltd Stock Comparison

Caplin Point Laboratories Ltd vs Natco Pharma Ltd Stock Comparison

Last Updated on: May 04, 2025

Key Highlights

  • The Latest Trading Price of Caplin Point Laboratories Ltd is ₹ 1884 as of 02 May 15:30.
  • The P/E Ratio of Caplin Point Laboratories Ltd changed from 9.9 on March 2020 to 21.9 on March 2024 . This represents a CAGR of 17.21% over 5 yearsThe P/E Ratio of Natco Pharma Ltd changed from 20 on March 2020 to 12.3 on March 2024 . This represents a CAGR of -9.26% over 5 years.
  • The Market Cap of Caplin Point Laboratories Ltd changed from ₹ 2135 crore on March 2020 to ₹ 10003 crore on March 2024 . This represents a CAGR of 36.18% over 5 yearsThe Market Cap of Natco Pharma Ltd changed from ₹ 9215 crore on March 2020 to ₹ 17042 crore on March 2024 . This represents a CAGR of 13.08% over 5 years.
  • The revenue of Caplin Point Laboratories Ltd for the Dec '24 is ₹ 524.32 crore as compare to the Sep '24 revenue of ₹ 503.87 crore. This represent the growth of 4.06% The revenue of Natco Pharma Ltd for the Dec '24 is ₹ 651.1 crore as compare to the Sep '24 revenue of ₹ 1434 crore. This represent the decline of -54.62%.
  • The ebitda of Caplin Point Laboratories Ltd for the Dec '24 is ₹ 193.64 crore as compare to the Sep '24 ebitda of ₹ 185.43 crore. This represent the growth of 4.43% The ebitda of Natco Pharma Ltd for the Dec '24 is ₹ 215.1 crore as compare to the Sep '24 ebitda of ₹ 868.1 crore. This represent the decline of -75.22%.
  • The net profit of Caplin Point Laboratories Ltd changed from ₹ 104.23 crore to ₹ 140.07 crore over 7 quarters. This represents a CAGR of 18.40% The net profit of Natco Pharma Ltd changed from ₹ 420.3 crore to ₹ 132.4 crore over 7 quarters. This represents a CAGR of -48.32% .
  • The Dividend Payout of Caplin Point Laboratories Ltd changed from 9.57 % on March 2020 to 13.39 % on March 2024 . This represents a CAGR of 6.95% over 5 yearsThe Dividend Payout of Natco Pharma Ltd changed from 25.89 % on March 2020 to 13.01 % on March 2024 . This represents a CAGR of -12.86% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Caplin Point Laboratories Ltd

  • Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16th, 1990.
  • The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
  • Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
  • It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
  • In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.

About Natco Pharma Ltd

  • Natco Pharma Limited was originally incorporated on 19 September 1981 as private limited company under the name of Natco Fine Pharmaceuticals Private Limited.
  • It became a deemed public company with effect from 1 July 1992.
  • The name of the company was changed to Natco Pharma Limited and a fresh certificate of incorporation consequent upon change of name was issued by the RoC, Andhra Pradesh on 18 February 1993.
  • The company was converted into a public limited company and a fresh certificate of incorporation dated 30 December 1994 was issued by the RoC, Andhra Pradesh. Natco Pharma is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs).
  • The Company's focus is primarily on niche therapeutic areas and complex products.

Caplin Point Laboratories Ltd News Hub

News

Caplin Steriles receives USFDA approval for Phytonadione Injectable Emulsion

Caplin Point Laboratories announced that its subsidiary, Caplin Steriles, has been granted...

Read more

23 Apr 2025 12:59

News

Caplin Point Lab arm receives final approval for Phytonadione Injectable Emulsion

The approved product is a generic therapeutic equivalent of the Reference Listed Drug (RLD...

Read more

23 Apr 2025 11:29

News

Caplin Steriles receives USFDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution

Caplin Steriles (Caplin), a subsidiary company of Caplin Point Laboratories has been grant...

Read more

26 Feb 2025 19:15

News

Caplin Point Lab's subsidiary gets USFDA approval for new eye drop solution

The said drug is a generic therapeutic equivalent version of the Reference Listed Drug (RL...

Read more

26 Feb 2025 14:17

News

Caplin Steriles receives USFDA approval for Procainamide Hydrochloride Injection

Caplin Steriles, a Subsidiary Company of Caplin Point Laboratories, has been granted final...

Read more

05 Feb 2025 20:06

News

Caplin Point Laboratories to hold board meeting

Caplin Point Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

01 Feb 2025 10:02

Natco Pharma Ltd News Hub

News

Natco Pharma update on launch of Risdiplam in India

Natco Pharma today updates on the legal proceedings on Risdiplam launch in India. The Comp...

Read more

08 Apr 2025 11:16

News

Natco Pharma Ltd up for fifth session

Natco Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 8...

Read more

07 Mar 2025 13:00

News

Natco Pharma Ltd soars 1.69%

Natco Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 837...

Read more

25 Feb 2025 13:05

News

Natco Pharma slips as Q3 PAT slides 38% YoY to Rs 132 cr

Profit before tax in Q3 FY25 stood at Rs 163.7 crore, down 36.13% as against Rs 256.3 cror...

Read more

13 Feb 2025 11:11

News

Natco Pharma Ltd drops for fifth straight session

Natco Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 997, ...

Read more

13 Feb 2025 13:35

News

Natco Pharma Ltd leads losers in 'A' group

Orchid Pharma Ltd, Vijaya Diagnostic Centre Ltd, FDC Ltd and Aegis Logistics Ltd are among...

Read more

13 Feb 2025 15:00

SWOT Analysis Of Caplin Point Laboratories Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Natco Pharma Ltd

Strength

4

S

Weakness

3

W

Opportunity

1

O

Threats

1

T

BlinkX Score for Caplin Point Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Natco Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Caplin Point Laboratories Ltd and Natco Pharma Ltd

Which company has a larger market capitalization, Caplin Point Laboratories Ltd or Natco Pharma Ltd?

Market cap of Caplin Point Laboratories Ltd is 14,323 Cr while Market cap of Natco Pharma Ltd is 15,071 Cr

What are the key factors driving the stock performance of Caplin Point Laboratories Ltd and Natco Pharma Ltd?

The stock performance of Caplin Point Laboratories Ltd and Natco Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Caplin Point Laboratories Ltd and Natco Pharma Ltd?

As of May 4, 2025, the Caplin Point Laboratories Ltd stock price is INR ₹1884.35. On the other hand, Natco Pharma Ltd stock price is INR ₹841.45.

How do dividend payouts of Caplin Point Laboratories Ltd and Natco Pharma Ltd compare?

To compare the dividend payouts of Caplin Point Laboratories Ltd and Natco Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions